1.
Rev Med Chir Soc Med Nat Iasi
; 105(4): 756-9, 2001.
Article
in Romanian
| MEDLINE
| ID: mdl-12092233
ABSTRACT
Nebivolol is a lipophilic beta 1-blocker. It is devoid of intrinsic sympathomimetic or membrane stabilising activity but appears to have nitric oxide-mediated vasodilatory effects. Nebivolol 5 mg once daily is well tolerated in patients with hypertension. Adverse events are infrequent, transient and mild to moderate. Those reported most often include headache, fatigue, paraesthesias and dizziness. Several studies reported no signs of orthostatic hypotension with Nebivolol.